Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 628.

https://doi.org/10.1182/blood-2019-122379

Published: 2019

Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Blood (2019) 134 (Supplement_1): 494.

https://doi.org/10.1182/blood-2019-123674

Published: 2019

Journal Articles

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Mark Roschewski, MD, Christopher Melani, MD, Kieron Dunleavy, MD, Matthias Holdhoff, MD PhD, Lode J. Swinnen, MB ChB, Michael Glantz, MD PhD, Craig A. Portell, MD, Jakub Svoboda, MD, Rafic Farah, MD, Michail S. Lionakis, MD ScD, Louis Staudt, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 2875.

https://doi.org/10.1182/blood-2019-123552

Published: 2019

Journal Articles

Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps Study

Nicola Conran, PhD, Kleber Yotsumoto Fertrin, MD PhD, Claudia de Alvarenga Maximo, MD, Thais Oliveira, B.Sc., Clarisse Lobo, MD PhD, Fernando Ferreira Costa, MD PhD

Blood (2019) 134 (Supplement_1): 2303.

https://doi.org/10.1182/blood-2019-130106

Published: 2019

Journal Articles

TEM-MM-101: A Phase I/IIa Dose Escalation Study Evaluating the Safety and Activity of Autologous CD34+ Enriched Hematopoietic Progenitor Cells Genetically Modified for Human Interferon-α2 in Multiple Myeloma Patients with Early Relapse after Intensive Front Line Therapy

Bernhard Gentner, MD, Francesca Farina, MD, Matteo Giovanni Carrabba, MD, Magda Marcatti, MD, Stefania Girlanda, MD, Gabriele Antonarelli, MD, Capotondo Alessia, PhD, Stefania Mazzoleni, PhD, Carlo Russo, MD, Luigi Naldini, MD PhD, Fabio Ciceri, MD

Blood (2019) 134 (Supplement_1): 2064.

https://doi.org/10.1182/blood-2019-123749

Published: 2019

Journal Articles

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2101.

https://doi.org/10.1182/blood-2019-122255

Published: 2019

Journal Articles

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Marie Claire McLintock, MD, Renee Eslick, MBBS, Stephanie Cox

Blood (2018) 132 (Supplement 1): 3802.

https://doi.org/10.1182/blood-2018-99-119405

Published: 2018

Journal Articles

Self-Reported Reproductive Health Experiences in Women with Von Willebrand Disease: A Qualitative Interview-Based Study

Ariela L. Marshall, MD, Harika Dasari, MBBS, Nathaniel D Warner, Diane E. Grill, Aneel A. Ashrani, MD MS, William L. Nichols, Jr., MD, Rajiv K. Pruthi, MD

Blood (2017) 130 (Supplement 1): 5588.

https://doi.org/10.1182/blood.V130.Suppl_1.5588.5588

Published: 2017

Journal Articles

Exploring Attitudes, Beliefs and Behavior Towards Hormonal Birth Control Among Female Patients with Sickle Cell Disease through Semi-Structured Interviews

Piper Kendra, PhD MPH1, Fuad El Rassi, MD, Morgan L. McLemore, MD, Melissa Kottke,

Blood (2017) 130 (Supplement 1): 4798.

https://doi.org/10.1182/blood.V130.Suppl_1.4798.4798

Published: 2017

Journal Articles

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Blood (2017) 130 (Supplement 1): 899.

https://doi.org/10.1182/blood.V130.Suppl_1.899.899

Published: 2017

Journal Articles

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Emily Riehm Meier, MD MSHS, Amy Dawson, MD, Natalie Duncan, MPH, Dennis O'Brien, MD, Anne Greist, MD

Blood (2017) 130 (Supplement 1): 2077.

https://doi.org/10.1182/blood.V130.Suppl_1.2077.2077

Published: 2017

Journal Articles

Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience

Rita Assi, MD, Hagop M. Kantarjian, MD, Michael J. Keating, MD, Naveen Pemmaraju, MD, Srdan Verstovsek, MD PhD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, Jenny Dahl, MS, PA-C, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 2881.

https://doi.org/10.1182/blood.V130.Suppl_1.2881.2881

Published: 2017

Journal Articles

Coagulation Kinetics in Adolescent Females Initiating Combined Oral Contraceptives

Fareeda W. Haamid, DO, Bryce A. Kerlin, MD, Sarah H. O'Brien, MD MSc, Brittny E. Manos, BA, Amanda P. Waller, PhD, Andrea E. Bonny, MD

Blood (2017) 130 (Supplement 1): 4904.

https://doi.org/10.1182/blood.V130.Suppl_1.4904.4904

Published: 2017

Journal Articles

The Impact of a Multidisciplinary Sickle Cell and Gynecology Clinic

Vardya A Tasha, MD

Blood (2016) 128 (22): 1319.

https://doi.org/10.1182/blood.V128.22.1319.1319

Published: 2016

Journal Articles

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

Laure Joseph, MD, Anoosha Habibi, MD, Giovanna Cannas, MD, Stephanie Ngo, MD, Sylvain Le Jeune, MD, Ersi Voskaridou, MD, Elena Foïs, MD, Caroline Makowski, MD, Nathalie Lemonne, MD, Narcisse Elenga, MD, Yves Ville, MD PhD, Alexandra Benachi, MDPhD, Robert Girot, MD, Marina Cavazzana, MD PhD, Jean-Antoine Ribeil, MD PhD

Blood (2016) 128 (22): 1309.

https://doi.org/10.1182/blood.V128.22.1309.1309

Published: 2016

Journal Articles

The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making: A Qualitative Patient-Oriented Survey Study

Ariela L. Marshall, MD, Juliana Perez Botero, MD, John A. Heit, Aneel A. Ashrani, MD MS, Rajiv K. Pruthi, MD, Ashish V. Chintakuntlawar, MD PhD, Jennifer Guenther, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 3588.

https://doi.org/10.1182/blood.V128.22.3588.3588

Published: 2016

Journal Articles

Cardiometabolic and Hemostatic Profiles of Women Carriers of Hemoglobin Variants Using Combined Oral Contraceptives

Junia Raquel Dutra Ferreira, MSc, Caroline Conceição Guarda, MSc, Rayra Pereira Santiago, MSc, Luane Rocha, Graduated, Jessica SANTOS Ferreira, Graduated, Luís Araújo, Graduated, Barbara Mota, Graduated, Thassila Nogueira Pitanga, PhD, Milena Magalhães Milena, MSc, Magda Seixas Carvalho, PhD, Elisangela Vitoria Adorno, PhD, Marilda Souza Goncalves, PhD

Blood (2016) 128 (22): 4851.

https://doi.org/10.1182/blood.V128.22.4851.4851

Published: 2016

Journal Articles

Contraceptive in Women with Sickle Cell Disease: A Survey Study

Natalie S Whaley, MD MPH, Sophie Lanzkron, MD MHS, Anne Burke, MD MPH

Blood (2015) 126 (23): 3263.

https://doi.org/10.1182/blood.V126.23.3263.3263

Published: 2015

Journal Articles

Referral Practices in Management of Heavy Menstrual Bleeding in Adolescents

Katherine I Foster, BA, Terah L Koch, MPH, Sarah H O'Brien, MD MSc

Blood (2014) 124 (21): 4835.

https://doi.org/10.1182/blood.V124.21.4835.4835

Published: 2014

Journal Articles

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory (IMiD) Drug Lenalidomide Produces Durable Responses in Patients with Heavily Pretreated Relapsed Lymphoma

Brenda Ernst, MD, Amylou Constance Dueck, PhD, Angela Toro, NP, Patrick B. Johnston, MD PhD, Thomas Haberman, MD, Jose F. Leis, MD PhD, Joseph R. Mikhael, MD, Grzegorz S. Nowakowski, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, James L Slack, MD, Stephen M. Ansell, MD PhD, Thomas E. Witzig, MD, Craig B. Reeder, MD

Blood (2014) 124 (21): 3100.

https://doi.org/10.1182/blood.V124.21.3100.3100

Published: 2014

NARROW

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Reponse-Adapted Study of Ibrutinib with Temozolomide, Etoposide, Doxil, Dexamethasone, and Rituximab (TEDDI-R) in Aggressive B-Cell Lymphomas with Secondary Involvement of the CNS

Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps Study

TEM-MM-101: A Phase I/IIa Dose Escalation Study Evaluating the Safety and Activity of Autologous CD34+ Enriched Hematopoietic Progenitor Cells Genetically Modified for Human Interferon-α2 in Multiple Myeloma Patients with Early Relapse after Intensive Front Line Therapy

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Self-Reported Reproductive Health Experiences in Women with Von Willebrand Disease: A Qualitative Interview-Based Study

Exploring Attitudes, Beliefs and Behavior Towards Hormonal Birth Control Among Female Patients with Sickle Cell Disease through Semi-Structured Interviews

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Management of Chronic Myeloid Leukemia (CML) during Pregnancy Among Patients (pts) Treated with a Tyrosine Kinase Inhibitor (TKI): A Single-Center Experience

Coagulation Kinetics in Adolescent Females Initiating Combined Oral Contraceptives

The Impact of a Multidisciplinary Sickle Cell and Gynecology Clinic

Hydroxycarbamide (HU), Sickle Cell Disease and Pregnancy, a Multicentric Retrospective Study

The Impact of Antithrombin Deficiency on Women's Reproductive Health Experiences and Healthcare Decision-Making: A Qualitative Patient-Oriented Survey Study

Cardiometabolic and Hemostatic Profiles of Women Carriers of Hemoglobin Variants Using Combined Oral Contraceptives

Contraceptive in Women with Sickle Cell Disease: A Survey Study

Referral Practices in Management of Heavy Menstrual Bleeding in Adolescents

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory (IMiD) Drug Lenalidomide Produces Durable Responses in Patients with Heavily Pretreated Relapsed Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only